Velocity Clinical Research, Omaha — Omaha, Nebraska

Velocity Clinical Research, Omaha is a clinical research site located in Omaha, Nebraska, United States 68134.

Crixeo Clinical Trials Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Omaha has participated in 21 clinical trials with 5 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, Obesity.

Sponsors: BioNTech SE, Pfizer, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Omaha?

Velocity Clinical Research, Omaha has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Omaha conducted?

Velocity Clinical Research, Omaha has 21 clinical trials on record, with 5 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, Obesity.

Is Velocity Clinical Research, Omaha accredited by Crixeo Clinical Trials?

Velocity Clinical Research, Omaha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research, Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.